Riluzole Hydrochloride serves as an essential medication primarily indicated for the treatment of amyotrophic lateral sclerosis and various motor neuron diseases, functioning by reducing glutamate-mediated… Read more
Riluzole Hydrochloride serves as an essential medication primarily indicated for the treatment of amyotrophic lateral sclerosis and various motor neuron diseases, functioning by reducing glutamate-mediated neurotoxicity. As a benzothiazole derivative, this compound requires rigorous quality control throughout pharmaceutical development to ensure safety and regulatory compliance. This category contains Riluzole Hydrochloride reference standards, along with related pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these high-quality materials for precise analytical testing, method validation, and impurity profiling to monitor degradation pathways and ensure accurate quantification in complex matrices. By incorporating these materials into routine workflows, research facilities can maintain consistency and reliability in their testing procedures while adhering to international standards for drug analysis and safety evaluation.